To confirm the prognostic value of BAL1 and BAL2 in BC patients, we performed Kaplan–Meier plotter analysis to access the RFS curves across different molecular subtypes of BC (Figs. 5 and 6). The gene discussed is PARP14; the disease is breast cancer.